Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., ...

Dyadic International, Inc.: Global Collaborations Continue to Validate Dyadic's C1 Platform and Expands Commercial Potential

C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ...
The Print on MSN

What is SpudCell? The world’s first synthetic cell, claim scientists

Researchers at the University of Minnesota claim to have created the first synthetic cell. They are calling it SpudCell, ...
Netmums on MSN

The number one laundry mistake that can permanently set sun cream stains into clothes

The problem lies in a quiet interaction between modern sun creams, the hard water found across much of the UK and the ...
Edhat

Yang Group Develops New Mechanism for Metal Carbene Radical Cross Coupling

In an effort to open the door to new and useful products, chemistry researchers are on the continual lookout for processes ...